UNITED STATES ~~SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549~~

~~_________________~~SECURITIES AND EXCHANGE COMMISSION

~~FORM~~Washington, D.C. ~~8-K~~20549

~~_________________~~FORM 8-K

CURRENT REPORT ~~PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934~~

~~Date~~PURSUANT TO ofSECTION ~~Report~~13 ~~(Date~~OR ~~of earliest event reported~~15(d): ~~October~~OF ~~14, 2005~~THE

~~_________________~~SECURITIES EXCHANGE ACT OF 1934

~~MICROTEK~~Date of ~~MEDICAL~~Report ~~HOLDINGS, INC.~~ (~~Exact~~Date ~~name~~ of ~~registrant~~earliest asevent ~~specified~~reported): inMarch ~~its~~6, ~~charter)~~ 2007

~~_________________~~ _______________________

Georgia	0-24866	58-1746149
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

MICROTEK MEDICAL HOLDINGS, INC.

~~13000 Deerfield~~(Exact ~~Parkway,~~ name ~~Suite~~of ~~300,~~registrant ~~Alpharetta,~~as ~~Georgia~~specified ~~30004~~in its ~~(Address of principal executive office~~charter) ~~(zip code)~~

~~Registrant’s telephone number, including area code: (678) 896-4400~~_________________________

______________________________________________ (Former name or former address, if changed since last report)

Georgia	0-24866	58-1746149
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

~~_________________~~13000 Deerfield Parkway, Suite 300, Alpharetta, Georgia 30004

~~Check~~(Address ~~the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation~~ of ~~the~~principal ~~registrant~~executive ~~under~~office) ~~any of the following provisions~~ (~~see~~zip ~~General Instruction A.2. below~~code):

~~|_|~~Registrant's telephone ~~Written~~number, ~~communications~~including ~~pursuant~~area tocode: ~~Rule 425 under the Securities Act~~ (~~17 CFR 230.425~~678) 896-4400

~~|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)~~__________________________________________________

~~|_| Pre-commencement communications pursuant to Rule 14d-2~~(b)Former name ~~under~~or ~~the~~former ~~Exchange~~address, ~~Act~~if ~~(17~~changed ~~CFR~~since ~~240.14d-2(b~~last report))

~~|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))~~_________________________

~~Item~~Check the appropriate ~~2.02~~box ~~Results~~below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of ~~Operations~~the ~~and~~registrant ~~Financial~~under ~~Condition~~any of the following provisions (see General Instruction A.2. below):

Ono ~~October~~Written ~~14,~~communications ~~2005,~~pursuant ~~Microtek~~to ~~Medical~~Rule ~~Holdings,~~425 ~~Inc.~~under (the ~~“Company”)~~Securities ~~issued~~Act a(17 ~~press~~CFR ~~release announcing its anticipated net revenues for the quarter ended September 30, 2005~~230. ~~This press release is attached as Exhibit 99.1 to this report and is incorporated herein by reference.~~425)

~~Item~~o ~~9.01~~Soliciting ~~Financial~~material ~~Statements~~pursuant ~~and~~to ~~Exhibits~~Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(ab) ~~Financial~~under ~~Statements.~~the ~~N/A~~Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(bc) ~~Pro~~under ~~Forma~~the ~~Financial~~Exchange ~~Information.~~Act ~~N/A~~(17 CFR 240.13e-4(c))

~~(c)~~Item 2.02 ~~Exhibits~~Results of Operations and Financial Condition.

On March 6, 2007, Microtek Medical Holdings, Inc. (the “Company”) issued a press release announcing its operating results for the quarter and twelve months ended December 31, 2006. This press release is attached as Exhibit ~~Number~~99.1 ~~Description~~to this report and is incorporated herein by reference.

99Item 9.101 ~~Press~~Financial ~~release~~Statements ~~dated~~and ~~October 14, 2005, announcing the Company's anticipated net revenues for the quarter ended September 30, 2005~~Exhibits.

~~-2-~~(a) Financial statements of businesses acquired.

~~SIGNATURES~~N/A

~~Pursuant~~(b) Pro ~~to the requirements of the Securities Exchange Act of 1934, the Company has duly caused~~ forma ~~this~~ financial ~~report to be signed on its behalf by the undersigned hereunto duly authorized~~information.

	MICROTEK MEDICAL HOLDINGS, INC.
Date: October 14, 2005	By: /s/ Dan R. Lee
	Dan R. Lee, Chairman, President and Chief Executive Officer
	By: /s/ Roger G. Wilson
	Roger G. Wilson, Chief Financial Officer

N/A

~~-3-~~(c) Shell company transactions.

~~EXHIBIT INDEX~~N/A

~~Exhibit Number Description~~(d) Exhibits.

99.1 Press release dated October 14, 2005, announcing the Company's anticipated net revenues for the quarter ended September 30, 2005

	Exhibit Number	Description

	99.1	Press release dated March 6, 2007, announcing the Company’s operating results for the quarter and twelve months ended December 31, 2006

-42-

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	MICROTEK MEDICAL HOLDINGS, INC.



Date: March 6, 2007	By: /s/ Dan R. Lee
	Dan R. Lee, Chairman, President and Chief Executive Officer

	By: /s/ Roger G. Wilson
	Roger G. Wilson, Chief Financial Officer

-3-

EXHIBIT INDEX

Exhibit Number	Description

99.1	Press release dated March 6, 2007, announcing the Company’s operating results for the quarter and twelve months ended December 31, 2006

-4-

Filing Compare · MICROTEK MEDICAL HOLDINGS, INC